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Objective: HLA-C*04:82 is a low incidence HLA-C allele. The aim here is to report the ethnicity of C*04:82
and its associated HLA haplotypes among Taiwanese individuals.
Materials and Methods: A sequence-based typing method was used to conﬁrm this low incidence allele.
Polymerase chain reaction was performed to amplify exons 2 and 3 of the HLA-A, HLA-B, and HLA-C loci
and exon 2 of the HLA-DRB1 locus using group-speciﬁc primer sets. The amplicons were sequenced in
both directions using Terminator Cycle Sequencing Ready Reaction kits and the manufacturer’s protocols.
The potential unrelated bone marrow stem cell donors in this study were randomized individuals with
Taiwanese ethnicity who participated in the Tzu Chi Bone Marrow Donor Registry. The family members
in the family part of the study were volunteer blood donors.
Results: The DNA sequence of C*04:82 was identical to C*04:01:01:01 in exons 2, 3, and 4. It differed
from C*04:01:01:01 in exon 5 where a segment of nucleotides (CTAGCTGTC) was inserted between
residues 969 and 970 of C*04:01:01:01. The insertion of these nucleotides caused a 35 amino acid
alteration to the protein sequence of C*04:01:01:01. Three probable HLA haplotypes that were associated
with C*04:82 among Taiwanese individuals were deduced. Conﬁrmation of the DNA and protein se-
quences of C*04:82 and its Taiwanese ethnicity were established in this study.
Conclusion: The ethnicity of the C*04:82 allele and the deduced probable HLA haplotypes associated
with the low-incidence C*04:82 allele are of value for reference purposes for HLA testing laboratories. In
addition, they can be used by search coordinators to aid the creation of a strategy for ﬁnding compatible
stem cell donors for patients who carry this uncommon HLA allele.
Copyright © 2016, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
New HLA alleles continue to be revealed and recognition of HLA
low-incidence alleles has enriched our understanding of the
complexity of the HLA system. The major histocompatibility com-
plex (MHC) in humans consists of several loci of genes that are
located on the short arm of chromosome 6 at 6p21.3. These loci are
classiﬁed into MHC class I, class II and class III regions. The genes
encoding the HLA alleles are located in the MHC Class I and Class IIells Centre, Hualien Tzu Chi
alien, Taiwan. Tel.: þ886
lief Tzu Chi Foundation. Publishedregions. The HLA genes are characterized by their extreme allelic
polymorphism as well as their variations and diversity across
different ethnic groups. HLA molecules have been deﬁnitively
deﬁned as transplant antigens and have a strong relevance to tissue
transplantation. The molecular similarity of these molecules be-
tween donors and recipients is considered to be a predictive factor
for graft survival and graft versus host disease. It is imperative to
precisely characterize any unknown and low-incidence alleles
encountered during routine HLA typing. To facilitate successful and
comprehensive unrelated bone marrow hematopoietic stem cell
donor searches, persistent efforts are needed to resolve unidenti-
ﬁed, ambiguous, or low-incidence alleles in order to offer better
HLA matching and donor selection.
The nucleotide sequence of HLA-C*04:82 was ﬁrst submitted to
GenBank and the IMGT/HLA database (Accession No. FN550110;by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
K.-L. Yang / Tzu Chi Medical Journal 28 (2016) 99e102100Cell ID LHLAS 000678) in September 2009, and the name HLA-
C*04:82 ofﬁcially assigned by the World Health Organization HLA
Nomenclature Committee [1,2]. The donor is reported to be a Chi-
nese individual. In 2013, a second individual (Cell ID D10044420)
with C*04:82 was reported to the IMGT/HLA database by a labo-
ratory in China [1]. For both these cases, however, there was no
indication of C*04:82 associated HLA haplotypes. Here, we report
the Taiwanese ethnicity of C*04:82 and the deduced probable HLA
haplotypes associated with C*04:82, based on one family study and
the HLA-A, HLA-B, HLA-C, and HLA-DRB1 alleles commonly shared
across our randomized unrelated bone marrow stem cell donors
and the two donors whose data were submitted to the IMGT/HLA
database [1]. We further speculate that the deduced plausible HLA
haplotypes associated with C*04:82 are restricted to individuals
who are members of the Chinese and Taiwanese ethnic groups.
2. Materials and methods
Peripheral whole blood samples from a family consisting of ﬁve
members and a range of unrelated bone marrow hematopoietic
stem cell donors with Taiwanese ethnicity were collected in acid
citrate dextrose anticoagulant. Formal written consent was indi-
vidually given by the donors before blood collection. The acid cit-
rate dextrose whole blood samples were stored at 80C until use.
Peripheral blood genomic DNA was extracted using QIAamp DNA
Blood Mini kits (Qiagen, Hilden, Germany). The DNA obtained was
subjected to HLA genotyping for the HLA-A, HLA-B, HLA-C, and
HLA-DRB1 loci using commercial polymerase chain reaction
sequencing based typing kits (Secore A/B/C/DRB1 Locus Sequencing
kits; Life Technologies, Brown Deer, WI, USA). High-resolution
allelic sequencing was performed as previously described [3e8].
Two sets of primer sequences used were: (1) B-CG: M13-BIN1-CGG
(sense): TGTAAAACGACGGCCAGTCGGGGGCGCAGGACCCGG; P3'
exon 5B (anti-sense): GCTCCGATGACCACAACTGCT; and (2) B-TA:
M13-BIN1-TGA (sense): TGTAAAACGACGGCCAGTGGCGGGGGCG-
CAGGACCTGA; P3'exon 5B (anti-sense): GCTCCGATGACCA-
CAACTGCT. The amplicons were then sequenced in both directions
using a BigDye Terminator Cycle Sequencing Ready Reaction kit
(Applied Biosystems, Foster City, CA, USA).
Determination of the deduced C*04:82 associated probable HLA
haplotypes in this study involved looking at the commonly shared
HLA typing of the donors carrying C*04:82 in one family under
study and in the randomized unrelated donors who form the Tzu
Chi Bone Marrow Donor Registry. Where applicable, haplotype
deduction based on HLA allelic homozygosity, as described previ-
ously, was used [9,10]. For example, if a donor was typed for HLA-A,
HLA-B and HLA-DRB1 as having A*33:03, , B*58:01, , DRB1*03:01,
, it was possible to deduce the putative haplotypes of the donor
derived from the biological parents to be HLA-A*33:03-B*58:01-
DRB1*03:01 and A*33:03-B*58:01-DRB1*03:01, respectively. Simi-
larly, if the typing of a donor was A*02:01, A*02:07, B*46:01, ,
DRB1*09:01, , then the putative haplotypes of the donor are
A*02:01-B*46:01-DRB1*09:01 and A*02:07-B*46:01-DRB1*09:01
[10].Fig. 1. The DNA sequence of C*04:82 was identical to C*04:01:01:01 in exons 2, 3 and 4 bu
(shaded) was inserted between residues 969 and 970 of C*04:01:01:01. Dashes indicate nu3. Results
The frequency of HLA-C*04:82 was found to be about 0.048%
based on the individuals analyzed in the present study, and in this
study the oriental ethnicity of C*04:82 was identiﬁed. In addition,
the report of Li et al [2] was conﬁrmed, whereby the DNA sequence
of C*04:82 was identical to that of C*04:01:01:01 in exons 2, 3 and
4 but differed from that of C*04:01:01:01 in exon 5 where a
segment of nucleotides (CTAGCTGTC) was inserted between resi-
dues 969 and 970 of C*04:01:01:01 (Fig. 1). This nucleotide inser-
tion led to the addition of three amino acids to the protein
sequence of C*04:01:01:01, stretching from residue 301 to residue
303 (Fig. 2). Table 1 shows a family study in which C*04:82 was
detected in the father and in two of his four children. In this family,
C*04:82 was consistently associated with A*24:02, B*40:01 and
DRB1*04:03 forming the haplotype A*24:02-B*40:01-C*04:82-
DRB1*04:03. However, among the unrelated bone marrow
(Table 2), all donors with C*04:82 were found to carry the B*40:01
allele, which is in full agreement with the family study (Table 1).
However, when HLA-A and HLA-DRB1 alleles were taken into
consideration, C*04:82 was found to be not restricted to A*24:02
and DRB1*04:03, respectively. Therefore, based on the studies of
the family and the randomized unrelated donors, we are able to
deduce three probable HLA-A and HLA-B haplotypes that were
associated with C*04:82 in Taiwanese individuals: A*24:02-
B*40:01-C*04:82; A*02:01-B*40:01-C*04:82; and A11- B*40:01-
C*04:82 (Tables 1 and 2). Furthermore, when the randomized
unrelated bone marrow stem cell donors were studied in detail,
the linkage between C*04:82 and DRB1 alleles was not consistent.
While it is clear that A*24:02 or DRB1*04:03 were found in some
donors with C*04:82, however, other HLA-A or DRB1 allele types
were also observed to coexist with C*04:82 (Table 2). Therefore,
the HLA-A, HLA-B and HLA-DRB1 haplotypes that were associated
with C*04:82 in the Chinese and Taiwanese populations can be
reported as polymorphic based on the present results.
4. Discussion
In this study, the Taiwanese ethnicity of C*04:82 was deter-
mined. Furthermore, based on the family study, C*04:82 was found
to be linked with A*24:02, B*40:01, and DRB1*04:03 to give the
haplotype A*24:02-B*40:01-C*04:82-DRB1*04:03 (Table 1). Simi-
larly, in the study of randomized potential unrelated bone marrow
stem cell donors (Table 2), C*04:82 was also found to be associated
with B*40:01. This observation indicates that there is a strong
linkage between C*04:82 and B*40:01. However, it was also
observed that when the HLA-A and HLA-DRB1 loci were examined,
C*04:82 was not restricted to an association with only one partic-
ular allele. Its associationwith the alleles in the HLA-A or HLA-DRB1
locus indicates haplotype polymorphism, which is in contrast to its
association with B*40:01 allele in the HLA-B locus.
It is worth mentioning that the most direct and classic method
to determine HLA haplotype is through family studies if suitable
test material from a number of key family members is available.t differed from C*04:01:01:01 in exon 5 where a segment of nucleotides (CTAGCTGTC)
cleotide identity with C*04:01:01:01.
Fig. 2. The nucleotide insertion described in Fig. 1 led to a three amino acid insertion into the protein sequence of C*04:01:01:01 from residue 301 to 303. This resulted in the
protein sequence of C*04:82 being changed greatly compared to C*04:01:01:01; there being 35 amino acid differences (shaded) in comparison with C*04:01:01:01. Dashes indicate
amino acid identity with C*04:01:01:01.
Table 1
Family study.a
Donor ID HLA-A* HLA-B* HLA-C* HLA-DRB1*
Father 24:02 e 40:01 e 03:04 04:82 04:03 04:05
Child 1 02:03 24:02 40:01 52:01 04:82 07:02 04:03 14:04
Child 2 02:03 24:02 40:01 52:01 04:82 07:02 04:03 14:04
Child 3 02:03 24:02 40:01 52:01 03:04 07:02 04:05 14:04
Child 4 11:01 24:02 40:01 e 03:04 e 04:05 15:01
Motherb 02:03 11:01 40:01 52:01 03:04 07:02 15:01 14:04
a In the family study, the father and Child 1 and 2 had the C*04:82 allele, which
was linked with A*24:02, B*40:01, and DRB1*04:03 (shaded) to form the haplotype
A*24:02-B*40:01-C*04:82-DRB1*04:03, which was associated with C*04:82.
b Haplotype deduced based on the family study.
Table 2
Stem cell donors study.a
Donor ID HLA-A* HLA-B* HLA-C* HLA-DRB1* HLA-DQB1*
160205 24:02 33:03 40:01 58:01 03:02 04:82 04:03 12:02 03:02 05:02
261462 02:01 11:01 40:01 48:01 03:04 04:82 15:01 15:02
281984 02:01 24:02 35:01 40:01 04:82 08:01 09:01 12:01 03:01 03:03
271591 11:01 24:02 40:01 51:01 04:82 14:02 04:03 11:01 03:01 03:02
239852 02:01 24:02 40:01 48:01 03:03 04:82 09:01 09:01
323581 02:01 02:07 40:01 51:01 04:82 15:02 04:03 14:05
310562 11:02 24:02 40:01 54:01 01:02 04:82 09:01 14:05
342662 11:01 11:01 15:02 40:01 04:82 08:01 04:03 12:02
362832 24:02 33:03 40:01 58:01 03:02 04:82 04:03 12:02 03:01 03:02
273635 02:01 24:02 40:01 40:02 04:82 15:02 04:03 04:05 03:02 04:01
057910 02:01 33:03 40:01 58:01 03:02 04:82 09:01 13:02
337441 02:07 24:02 40:01 40:55 04:82 15:02 04:03 04:05 03:02 04:01
D10044420 24:02 31:01 40:01 44:03 04:82 07:06 07:01 09:01
LHLAS000678 02:01 33:03 40:01 58:01 03:02 04:82 04:03 07:01
a Deduced probable HLA-A and HLA-B haplotypes associated with C*04:82 based on the proﬁles of randomized unrelated donors who were Taiwanese or Chinese as re-
ported by the IMGT/HLA database (underlined). In all cases, C*04:82 was linked with B*40:01 (shaded). However, when the HLA-A and HLA-DRB1 alleles were taken into
consideration, C*04:82 was not restricted to association with only one particular HLA-A or HLA-DRB1 allele. Only a few individuals display the A*24:02-B*40:01-C*04:82-
DRB1*04:03 haplotype (underlined).
K.-L. Yang / Tzu Chi Medical Journal 28 (2016) 99e102 101Alternatively, a population study may be used if a signiﬁcant
number of unrelated donors are available [4]. However, the hap-
lotypes deduced via a population investigation are considered to be
either likely or most probable.
Based on the analyses of the present family study (Table 1) and
the unrelated potential bone marrow stem cell donors who were
investigated (Table 2), at least three probable C*04:82 associated
HLA-A, HLA-B, and HLA-C haplotypes may be deduced, that is,
A*02:01-B*40:01-C*04:82; A11-B*40:01-C*04:82; and A*24:02-
B*40:01-C*04:82. However, in order to determine the HLA-A,
HLA-B, HLA-C, and HLA-DRB1 haplotypes that are associated with
C*04:82, a more extensive investigation that includes a greater
number of individuals bearing C*04:82 is essential.The signiﬁcance of determining the ethnicity of individuals with
C*04:82 and its HLA linked haplotypes is that this information may
now be used in anthropological investigation of races, and to help
search coordinators working at unrelated bone marrow donor
registries with the allocation of appropriate unrelated bone
marrow hematopoietic stem cell donors to their patients in need of
a transplant.
The number of known HLA alleles is increasing exponentially
due to recent developments in DNA-based molecular typing tech-
nology. The outstanding HLA diversity across ethnic groups is both
unique and important. Facilitating an appropriate HLA match for a
given unrelated bone marrow stem cell donor allows successfulstem cell transplantation and relies on the accuracy of HLA typing
and the spirit and strength to resolve the unknown, ambiguous,
and low-incidence genes still present in the HLA system. Addi-
tionally, determination of haplotype is essential whenmatching for
unrelated stem cell transplantation between donor and recipient,
since matching at the haplotype level has a better likelihood of
matching at other loci within the HLA region thanwhen donors are
merely matched at the individual allelic level.
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